http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021106596-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35d2b8ebf9c08a3302317845b3b5bf54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17 |
| filingDate | 2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2f0c2147dc20e756253de73a5141e7b |
| publicationDate | 2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021106596-A |
| titleOfInvention | Joint pain improving agent |
| abstract | PROBLEM TO BE SOLVED: To provide a joint pain improving agent exhibiting repetitive continuity of an excellent knee joint pain improving effect. SOLUTION: This is a joint pain improving agent containing non-denatured proteoglycan having an average molecular weight of 900,000 Da and non-denatured type II collagen having an average molecular weight of 300,000 Da to 400,000 Da as active ingredients, and is non-denatured. Contains proteoglycan and non-denatured type II collagen in a molecular weight ratio of 4.5: 10 to 5.5: 10. An arthralgia improving agent characterized by being for oral use. [Selection diagram] FIG. 7 |
| priorityDate | 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.